FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

Perhaps Ally McBeal can ease her off-the-charts stress levels by escaping to the office restroom. But for most of us, public toilets are actually a bit scary. If you squirm at the thought of ...

Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...

COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

There’s no one-size-fits all number that applies to everyone. “But we know that even 7% to 10% of weight loss can have a ...

New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.

Scalp psoriasis is a common skin disorder. It may look different on different skin tones. If you're light- to medium-skinned, it often shows up as raised, reddish, or salmon-colored patches with ...

Bone cancer is when cells in your bones grow out of control. Usually, when you have bone cancer, it comes from another cancer that has spread to your bones or metastatic bone cancer. But ...

If you've been on your share of amusement park rides, you probably know what vertigo is like — the feeling that the world is spinning around you. But if you feel dizzy and didn't just step off a ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.